Atlas Trials

Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI

Clinical trial NCT05594355 · UNKNOWN

Trial details

NCT number
NCT05594355
Sponsor
Fundació ACE Institut Català de Neurociències Aplicades
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Mild Cognitive Impairment (MCI)
Start date
2021-04-16
Primary completion
2023-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.